Mosaic ImmunoEngineering Inc (CPMV)

[IAMSAM]

Davis added, “We are very pleased to add Intel’s former Group General Counsel to the Alliacense team. Carl’s extensive semiconductor industry insight will be a great asset as more and more global manufacturers are realizing the value and competitive edge they can achieve by becoming early purchasers of a Moore Microprocessor Patent™ (MMP) Portfolio license.

MMP Portfolio patents encompass fundamental design techniques that enable higher performance and lower cost digital electronic systems ranging from cell phones and portable music players to communications infrastructure and medical equipment as well as automobiles, which today utilize dozens of microprocessors.